Montreal cancer company Repare inks deal with Roche worth more than US$1B - Montreal | Globalnews.ca

drug company, which is working on highly-targeted therapies, says Roche will help develop and commercialize the drug camonsertib.for the treatment of tumors.

Repare says under the terms of the licence and collaboration agreement, it will receive a US$125 million upfront payment, and is “eligible to receive up to US$1.2 billion in potential clinical, regulatory, commercial and sales milestones.”

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว